Device Trial Radar · NCT03065465
Standard Endoscopic Hemostasis Versus OVESCO Severe Non-variceal UGI Hemorrhage
Last checked: Nov 20, 2026Latest source record: Aug 27, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
65
Planned (sponsor's estimate)
Start
Nov 15, 2015
Primary completion
Dec 24, 2024
Study completion Feb 28, 2025
Sponsor
- Lead sponsor
- CURE Digestive Diseases Research CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- University of California, Los Angeles; VA Greater Los Angeles Healthcare System
- First posted
- Feb 28, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, care provider)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 100 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The primary specific aim is to perform a randomized controlled trial (RCT) to compare 30 day rebleed rates and other clinical outcomes of patients with severe, non-variceal upper GI hemorrhage (NVUGIH) - ulcers and Dieulafoy's lesions who are randomized as initial treatment with the new large over-the-scope-clip device for endoscopic hemostasis versus standard endoscopic hemostasis.
Conditions
- Upper Gastrointestinal Hemorrhage
Interventions
Over-the-scope hemoclipping deviceDevice
A endoscopic entrapment of tissue for control of bleeding or other applications.
Standard endoscopic treatmentOther
Standard therapy includes injection of dilute epinephrine, thermal coagulation with multipolar electrocautery (MPEC) probe, and/or hemoclips.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The rebleeding rate of non-variceal focal UGI lesionsTime frame: Outcome measure will be assessed at 30 days after participants are enrolled
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
VA Greater Los Angeles Healthcare System
Los Angeles, California · Recruiting
University of California, Los Angeles
Los Angeles, California · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.